U.S. Colorectal Cancer Market

Frost & Sullivan
December 28, 2009
81 Pages - SKU: MC2554570
License type:
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a  |  more...
$3,995.00
Digestive Remedies in Dominican Republic
5/9/2012 | published by: Euromonitor International
Conditions in the digestive tract, such as gastritis and different bacteria viruses, have become the leading causes of patient consultations attending health centres in the Dominican Republic, according to data released by the Ministry of  |  more...
$900.00
Digestive Remedies in Guatemala
5/10/2012 | published by: Euromonitor International
In 2011, digestive remedies grew by 13% to GTQ46 million in terms of current value sales. Performance among digestive remedies is benefited by poor eating habits, stress and poor sanitary conditions. Water quality is also  |  more...
$900.00
Digestive Remedies in Ukraine
5/10/2012 | published by: Euromonitor International
In 2011, digestive remedies was one of the most modest performers with value sales up by 11% current value growth notwithstanding further price increases on medicines. Digestive remedies are not viewed as essential products for  |  more...
$900.00
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity Summary GBI Research, the leading  |  more...
$3,500.00
Digestive Remedies in Latvia
5/8/2012 | published by: Euromonitor International
In 2011 digestive remedies had substantial 9% growth to reach LVL5 million. The major driving forces were an increase in average unit price driven by inflation, and willingness of customers to purchase more expensive products  |  more...
$900.00
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors  |  more...
$3,995.00
Triple Analysis: Lymphoma, Melanoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in  |  more...
$5,175.00
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
4/30/2012 | published by: GBI Research
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules Summary GBI Research, the leading business intelligence provider, has released its latest research  |  more...
$3,500.00
Digestive Remedies in the Czech Republic
4/26/2012 | published by: Euromonitor International
Digestive remedies had value growth of 1% in 2011 which was only slightly lower compared to review period value CAGR. Sales of digestive remedies were driven by lifestyle and bad eating habits of many Czechs.  |  more...
$900.00